86 related articles for article (PubMed ID: 8372996)
1. Use of interferons in atopic (IgE-mediated) diseases.
Pung YH; Vetro SW; Bellanti JA
Ann Allergy; 1993 Sep; 71(3):234-8. PubMed ID: 8372996
[TBL] [Abstract][Full Text] [Related]
2. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma.
Jang IG; Yang JK; Lee HJ; Yi JY; Kim HO; Kim CW; Kim TY
J Am Acad Dermatol; 2000 Jun; 42(6):1033-40. PubMed ID: 10827410
[TBL] [Abstract][Full Text] [Related]
3. Successful interferon alpha therapy in atopic dermatitis of Besnier's prurigo pattern with normal serum IgE and blood eosinophil fraction: randomized case-controlled study.
Noh G; Lee KY
Cytokine; 2001 Jan; 13(2):124-8. PubMed ID: 11145854
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma therapy reduces blood leukocyte levels in patients with atopic dermatitis: correlation with clinical improvement.
Ellis CN; Stevens SR; Blok BK; Taylor RS; Cooper KD
Clin Immunol; 1999 Jul; 92(1):49-55. PubMed ID: 10413652
[TBL] [Abstract][Full Text] [Related]
5. [A case of hyperimmunoglobulin E syndrome with normal interferon-gamma production].
Sudo M; Shioya T; Miura K; Miura M
Arerugi; 1993 Dec; 42(12):1800-5. PubMed ID: 8110040
[TBL] [Abstract][Full Text] [Related]
6. In vivo levels of IL-4, IL-10, TGF-beta1 and IFN-gamma mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis.
Katagiri K; Arakawa S; Hatano Y
Arch Dermatol Res; 2007 Jan; 298(8):397-401. PubMed ID: 17021766
[TBL] [Abstract][Full Text] [Related]
7. Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis.
Schneider LC; Baz Z; Zarcone C; Zurakowski D
Ann Allergy Asthma Immunol; 1998 Mar; 80(3):263-8. PubMed ID: 9532976
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous administration of interferon alpha and gamma in patients with metastatic renal cell carcinoma.
Koga S; Nishikido M; Matsuya F; Kanetake H; Saito Y
Anticancer Res; 1999; 19(6C):5547-50. PubMed ID: 10697614
[TBL] [Abstract][Full Text] [Related]
9. Hyper-IgE syndromes.
Grimbacher B; Holland SM; Puck JM
Immunol Rev; 2005 Feb; 203():244-50. PubMed ID: 15661034
[TBL] [Abstract][Full Text] [Related]
10. Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design.
Schiller JH; Pugh M; Kirkwood JM; Karp D; Larson M; Borden E
Clin Cancer Res; 1996 Jan; 2(1):29-36. PubMed ID: 9816086
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
12. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
13. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
14. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
[TBL] [Abstract][Full Text] [Related]
15. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
16. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
Greenblatt MS; Mangalik A; Ferguson J; Elias L
Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
[TBL] [Abstract][Full Text] [Related]
17. Interferon in metastatic renal cell carcinoma.
Fosså SD
Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha after autologous stem cell transplantation in pediatric patients with advanced Hodgkin's lymphoma.
Petropoulos D; Worth LL; Mullen CA; Lockhart S; Choroszy M; Chan KW
Bone Marrow Transplant; 2006 Sep; 38(5):345-9. PubMed ID: 16915224
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric detection of type 1 (IL-2, IFN-gamma) and type 2 (IL-4, IL-5) cytokines in T-helper and T-suppressor/cytotoxic cells in rheumatoid arthritis, allergic asthma and atopic dermatitis.
Schuerwegh AJ; De Clerck LS; De Schutter L; Bridts CH; Verbruggen A; Stevens WJ
Cytokine; 1999 Oct; 11(10):783-8. PubMed ID: 10525317
[TBL] [Abstract][Full Text] [Related]
20. Blood eosinophils and serum IgE as predictors for prognosis of interferon-gamma therapy in atopic dermatitis.
Noh GW; Lee KY
Allergy; 1998 Dec; 53(12):1202-7. PubMed ID: 9930598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
